
Liminatus Pharma, Inc. (LIMN)
- Previous Close
5.63 - Open
5.53 - Bid 1.32 x 500
- Ask 0.11 x 2900
- Day's Range
5.15 - 5.88 - 52 Week Range
4.75 - 180.00 - Volume
116,539 - Avg. Volume
706,551 - Market Cap (intraday)
6.931M - Beta (5Y Monthly) 0.74
- PE Ratio (TTM)
-- - EPS (TTM)
-24.00 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 8/21/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Statistics
View MoreValuation Measures
-
Market Cap
6.92M
-
Enterprise Value
5.34M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
--
-
Price/Book (mrq)
23.01
-
Enterprise Value/Revenue
--
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-95.65%
-
Return on Equity (ttm)
--
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-12.52M
-
Diluted EPS (ttm)
-24.00
Balance Sheet and Cash Flow
-
Total Cash (mrq)
3.02M
-
Total Debt/Equity (mrq)
479.85%
-
Levered Free Cash Flow (ttm)
-10.01M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.

